Authors: Latif, F Tandon, S Obeleniene, R Hankins, SR Berlowitz, MS Ennezat, PV Le Jemtel, TH

Citation: F. Latif et al., Angiotensin II type 1 receptor blockade with 80 and 160 mg valsartan in healthy, normotensive subjects, J CARD FAIL, 7(3), 2001, pp. 265-268

Authors: Berlowitz, MS Latif, F Hankins, SR Ennezat, PV Moskowitz, R Tandon, S Colombo, PC Le Jemtel, TH

Citation: Ms. Berlowitz et al., Dose-dependent blockade of the angiotensin II type 1 receptor with losartan in normal volunteers, J CARDIO PH, 37(6), 2001, pp. 692-696

Authors: Jorde, UP Ennezat, PV Lisker, J Suryadevara, V Infeld, J Cukon, S Hammer, A Sonnenblick, EH Le Jemtel, TH

Citation: Up. Jorde et al., Maximally recommended doses of angiotensin-converting enzyme (ACE) inhibitors do not completely prevent ACE-mediated formation of angiotensin II in chronic heart failure, CIRCULATION, 101(8), 2000, pp. 844-846

Authors: Hamroff, G Katz, SD Mancini, D Blaufarb, I Bijou, R Patel, R Jondeau, G Olivari, MT Thomas, S Le Jemtel, TH

Citation: G. Hamroff et al., Addition of angiotensin II receptor blockade to maximal angiotensin-converting enzyme inhibition improves exercise capacity in patients with severe congestive heart failure, CIRCULATION, 99(8), 1999, pp. 990-992